Advances in stem cell therapy for spinal cord injury.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23114605.
- Also identified by DOI 10.1172/JCI64124 and PMC identifier 3484454.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Spinal cord injury (SCI) is a devastating condition producing great personal and societal costs and for which there is no effective treatment. Stem cell transplantation is a promising therapeutic strategy, though much preclinical and clinical research work remains. Here, we briefly describe SCI epidemiology, pathophysiology, and experimental and clinical stem cell strategies. Research in stem cell biology and cell reprogramming is rapidly advancing, with the hope of moving stem cell therapy closer to helping people with SCI. We examine issues important for clinical translation and provide a commentary on recent developments, including termination of the first human embryonic stem cell transplantation trial in human SCI.
Medical subject headings
- Biomedical Research
- Cell Dedifferentiation
- Spinal Cord Injuries
- Stem Cell Transplantation